ABSTRACT
Objective To compare the curative effect of ultrasound guided mammotome minimally invasive biopsy system and open operation in the treatment of benign breast mass .Methods 60 benign breast mass patients with total 115 phymas were selected as treatment group , and were given the mammotome minimally invasive biopsy treatment .60 benign breast mass patients with total 105 phymas who were given traditional open operation at the same time,were selected as control group .The treatment effect and satisfaction condition of patients in the two groups were compared.Results The phymas of patients in two groups were all removed by operation .The operation time,blood loss,healing time and scar size after operation in the treatment group were all shorter than those in the control group (t=2.41,3.87,2.44,9.84,P<0.05 or P<0.01).The incidence rate of postoperative complication in the treatment group (6.66%) was significantly lower than that in the control group (20.00%)(χ2 =4.62,P<0.05).The postop-erative satisfaction of patients in the treatment group (95.00%) was significantly higher than that in the control group (20.00%)(χ2 =5.26,P<0.05).Conclusion Compared with open operation ,ultrasound guided mammotome min-imally invasive biopsy system in the treatment of benign breast mass has advantages of shorter operative time ,smaller operative trauma ,shorter postoperative healing time ,less operative complication ,higher satisfaction of patients .
ABSTRACT
Objective To summarize and explore the clinical value of Mammotome technology in the diagnosis and treatment of breast neoplasms. Methods Nine hundred and eighty-seven breast neoplasms of 710patients were biopsied and excised with the aid of ultrasound-guided Mammotome system. The malignant neoplasms,according to the histological report,were radically removed during the operation without delay. All patients enrolled into the study were followed up closely on the complcations and satisfaction degree. Results All the operations except one were successful and got the sufficient specimen to perform the pathological examination,the biopsy achievement rate was 99. 8% . Both the sensitivity and specificity of the diagnosis were 100% in 16 breast tumors. Complete resection rate was 99%. The incision length was about 3 mm,showing good cosmetic outcome. Complcations were mild,mainly composed of haematoma and ecchymosis. The patients' general satisfactory rate was 93%. Conclusions This technique can help achieve biopsy of breast neplasm and excision of benign lesions at the same time with cosmetic result Further attention should be paid to reduce the lesion residue and hemorrhagic complications.
ABSTRACT
PURPOSE: Percutaneous vacuum-assisted breast biopsy (Mammotome, Fa. Ethicon Endo-Surgery Breast Care) is now commonly performed as the initial approach to diagnose and treat benign breast lesions. It can obviate the need for surgery in women with benign lesions and often lead to a one-stage surgical procedure when malignant lesions are diagnosed. The purpose of this study was to report the outcome of the Mammotome biopsy.. METHODS: We performed 902 cases of Mammotome biopsy (total 474 patients) to confirm the diagnosis and to excise the lesion between January 2003 and December 2006. Among all these cases, 888 cases with radiographically suspected benign lesions, below BI-RADS category 4, were followed up for more than 6 months and we analyzed clinical and pathologic results of these cases, retrospectively. Ultrasonographic follow-up examinations were performed and no malignant tumor or atypical ductal hyperplasia was included. RESULTS: The mean patient age was 42 (range: 17~76) years. The average size of lesion was 1.12 (range: 0.20~5.0) cm. In BI-RADS category, there were 450 (49.8%) C2 lesions, 158 (17.8%) C3 lesions and 251 (27.8%) C4 lesions. Histology revealed 506 cases (56.0%) of fibrocystic disease, 295 (32.7%) fibroadenomas, 11 (1.1%) intraductal papillomas, 16 cases (1.7%) of sclerosing adenosis, 21 cases (2.5%) of ductal epithelial hyperplasia, 18 cases (2.1%) of fat necrosis, 3 cases (0.3%) of gynecomastia, 18 cases (1.9%) of chronic inflammation. 824 lesions (92.8%) were completely removed, 39 cases (4.4%) of residual lesion and 25 cases (2.8%) of postoperative scar were reported. CONCLUSION: Mammotome biopsy is an effective diagnostic and therapeutic management of benign breast lesions with minimal-invasiveness and minimizes postoperative complications.